Research Article
Left Atrial Appendage Occlusion in High Bleeding Risk Patients
Table 2
Antithrombotic therapy before and after left atrial appendage closure.
| ā | Pretreatment | Posttreatment, discharge | Posttreatment, 3 months | Posttreatment, 6/12 months |
| n | 68 | 68 | 68 | 62 | No antithrombotic therapy | 16 (23.5%) | 5 (7.3%) | 10 (14.7%) | 20 (32.3%) | Single anti-platelet therapy | 12 (17.7%) | 29 (42.7%) | 40 (58.9%) | 34 (54.8%) | Dual anti-platelet therapy | 23 (33.8%) | 32 (47.1%) | 16 (23.5%) | 8 (12.9%) | Anticoagulant therapy | 17 (25.0%) | 2 (2.9%) | 2 (2.9%) | 0 (0.0%) |
|
|